SpectRx seeks buyer for insulin pump infusion set unit
This article was originally published in The Gray Sheet
Executive Summary
Firm's SimpleChoice insulin pump infusion set business is up for sale as part of a broader SpectRx reorganization aimed at refocusing the company on its noninvasive LightTouch cervical cancer detection technology, including funding ongoing pivotal trials of the device, the firm says March 15. SpectRx also is seeking a partner for its development-stage continuous glucose monitoring technology. LightTouch, which uses light to scan the cervix for disease, is intended as a triage step for women with positive Pap smear or human papillomavirus (HPV) tests to confirm whether colposcopy and biopsy are warranted (1"The Gray Sheet" Sept. 18, 2006, In Brief)...